搜索筛选:
搜索耗时0.4036秒,为你在为你在102,267,441篇论文里面共找到 3 篇相符的论文内容
发布年度:
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective:A, an oral, irreversible ErbB family blocker, was compared with GC in 364 Asian pts with EGFR mut positive NSCLC, including 327 pts from China.PFS was significantly prolonged with A vs GC in...
A multicenter, randomized, controlled trial of S-1/Cisplatin vs.Docetaxel/Cisplatin for treatment of
[会议论文] 作者：Baohui Han,Xiaoqing Liu,Gongyan Chen,Caicun Zhou,Jiwei Liu,Hongming Pan,Cheng Huang,Shucai Zhang,Jifeng Feng,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: Platinum based doublet chemotherapy is standard treatment for treatment na(i)ve advanced NSCLC pts, although molecularly targeted therapy can improve outcome of selected patients who harbor...
相关搜索：
